New diabetes clinical trial: Effectiveness of a Team-based Follow-up Program in General Practice Among People With Chronic Conditions | | |
New diabetes clinical trial: Acupuncture and Insulin Doses in Insulin-treated Type 2 Diabetes | | |
New diabetes clinical trial: The Effect of Dietary Nitrate on Blood Pressure, Insulin Sensitivity, and Vascular Function in Type 2 Diabetes | | |
New diabetes clinical trial: Effect of Extra Virgin Olive Oil on Postprandial Blood Glucose in Type 2 Diabetes Mellitus Patients | | |
New diabetes clinical trial: Methods of Early Detection and Grading Of Diabetic Peripheral Neuropathy (MEDON) | | Published on: September 05, 2019 at 07:00PM Conditions: Neuropathy, Diabetic; Neuropathy, Painful Interventions: Diagnostic Test: Perception Threshold Tracking (PTT); Diagnostic Test: Axon-flair mediated respons; Diagnostic Test: Heart rate variability; Diagnostic Test: Quantitative Sensory Testing (QST); Diagnostic Test: Peripheral blood pressure and transcutaneous oxygen tension; Diagnostic Test: Magnetic Resonance Imaging (MRI); Diagnostic Test: Questionnaires; Diagnostic Test: Corneal Confocal Microscopy /CCM) Sponsors: Aalborg University Hospital; Aalborg University Recruiting https://clinicaltrials.gov/ct2/show/NCT04078516?term=diabetes&sfpd_d=14 September 06, 2019 at 03:17PM via ClinicalTrials.gov |
New diabetes clinical trial: Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients | | |
New diabetes clinical trial: Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes | | |
New diabetes clinical trial: Impact of Body Composition and Exercise on Clinical, Metabolic and Molecular Parameters in Type 2 Diabetics in Qatar | | |
New diabetes clinical trial: Effect of Two Types of Education on HbA1c Level and Future Amputations in Inpatient Diabetics | | |
New diabetes clinical trial: Dining With Diabetes in Pennsylvania | | |
New diabetes clinical trial: Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients | | Published on: September 05, 2019 at 07:00PM Conditions: Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Insulin-Dependent Interventions: Biological: Intravenous Injection of autologous mesenchymal stem cells; Other: Intravenous injection of placebo Sponsors: Royan Institute; Tehran University of Medical Sciences; Iranian Stem Cell Council Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT04078308?term=diabetes&sfpd_d=14 September 06, 2019 at 03:17PM via ClinicalTrials.gov |
Няма коментари:
Публикуване на коментар